Paper Details

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Faculty Members have conducted research related to the The Standard Dose Versus Double Dose of N-Acetylcysteine to Prevent Contrast-Induced Nephropathy; a Randomized Controlled Clinical Trial

Hamid Reza Poorhosseini

Hamid Reza Poorhosseini

Professor of Cardiology

Department Cardiology

School of Medicine

Tehran Heart Center

Tehran University of Medical Sciences

Related Documents

1. Comparison of Oral and Intravenous N-Acetyl Cysteine in Preventing Contrast Nephropathy, Indian Journal of Nephrology (2020)

All Documents

1. Comparison of Machine-Learning Models for the Prediction of 1-Year Adverse Outcomes of Patients Undergoing Primary Percutaneous Coronary Intervention for Acute St-Elevation Myocardial Infarction, Clinical Cardiology (2024)

2. Heart Surgery Over Two Decades: What We Have Learned About Results and Changing Risks, BMC cardiovascular disorders (2024)

3. Effect of Diet Low in Advanced Glycation End Products on Appetite, Body Composition, and Brown Adipose Tissue Markers in Patients With Coronary Artery Disease Treated With Angioplasty: A Randomized Controlled Trial, Journal of Research in Medical Sciences (2023)

4. Opium As a Risk Factor for Early-Onset Coronary Artery Disease: Results From the Milano-Iran (Miran) Study, PLoS ONE (2023)

5. Clinical Presentation, Disease Course, and Outcome of Covid-19 in Hospitalized Patients With and Without Pre-Existing Cardiac Disease: A Cohort Study Across 18 Countries, European Heart Journal (2022)

6. Comparison of Angiographic and Clinical Outcomes After Primary Percutaneous Coronary Intervention for St-Elevation Myocardial Infarction Between Patients With and Without Concomitant Covid-19 Infection, Critical Pathways in Cardiology (2022)

7. Impact of Baseline Estimated Glomerular Filtration Rate Using Ckd-Epi Equation on Long-Term Prognosis of Stemi Patients: A Matter of Small Increments!, Critical Pathways in Cardiology (2022)

8. Intramyocardial Echo-Free Space With a Turbulent Flow Within, Suggestive of an Aneurysmal Coronary Artery, Echocardiography (2022)

9. Predictors of In-Hospital Mortality in Diabetic Patients With Non-St-Elevation Myocardial Infarction, Egyptian Heart Journal (2022)

10. Prevalence, Awareness, Treatment, and Control of Hypertension Among Adult Residents of Tehran: The Tehran Cohort Study, Global Heart (2022)

11. Sex Difference in the Risk Factor Distributions and Outcomes After Coronary Artery Bypass Graft Surgery in the Young Population, European Journal of Cardio-thoracic Surgery (2022)

12. Clinical Implications and Indicators of Mortality Among Patients Hospitalized With Concurrent Covid-19 and Myocardial Infarction, Turk Kardiyoloji Dernegi Arsivi (2021)

13. Management of St-Segment-Elevation Myocardial Infarction During the Coronavirus Disease 2019 (Covid-19) Outbreak: Iranian“247” National Committee's Position Paper on Primary Percutaneous Coronary Intervention, Catheterization and Cardiovascular Interventions (2021)

14. Management of St-Segment-Elevation Myocardial Infarction During the Coronavirus Disease 2019 (Covid-19) Outbreak: Iranian“247” National Committee's Position Paper on Primary Percutaneous Coronary Intervention, Catheterization and Cardiovascular Interventions (2021)

15. Predicting the Outcome in Confirmed Covid-19 Patients With Coronary Artery Disease: A Key Role for the First Chest Computed Tomography, Egyptian Heart Journal (2021)

16. Prevalence and Trends of Coronary Artery Disease Risk Factors and Their Effect on Age of Diagnosis in Patients With Established Coronary Artery Disease: Tehran Heart Center (2005–2015), BMC Cardiovascular Disorders (2021)

17. Prognostic Implications of Calculated Apo-Lipoprotein B in Patients With St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Outcome Is Tied to Lower Cut-Points, Clinical Cardiology (2021)

18. Tehran Cohort Study (Tecs) on Cardiovascular Diseases, Injury, and Mental Health: Design, Methods, and Recruitment Data, Global Epidemiology (2021)

19. The No-Reflow Phenomenon: Is It Predictable by Demographic Factors and Routine Laboratory Data?, Acta Biomedica (2021)

20. A Pseudoaneurysm of the Left Atrium As a Rare Source of Coronary Artery Embolization, Echocardiography (2020)

21. Comparison of Oral and Intravenous N-Acetyl Cysteine in Preventing Contrast Nephropathy, Indian Journal of Nephrology (2020)

22. Effect of Persistent Opium Consumption After Surgery on the Long-Term Outcomes of Surgical Revascularisation, European Journal of Preventive Cardiology (2020)

23. One-Year Outcome of Patients With Coronary Artery Ectasia Undergoing Percutaneous Coronary Intervention: Clinical Implications and Question Marks, Journal of Tehran University Heart Center (2020)

24. Opium and Cardiovascular Health: A Devil or an Angel?, Indian Heart Journal (2020)

25. Prosthetic Heart Valves and the Covid-19 Pandemic Era: What Should We Be Concerned About?, Journal of Cardiac Surgery (2020)

26. Relationship Between the Severity of Coronary Artery Disease and Cardiovascular Risk Factors in Acute Coronary Syndrome: Based on Tehran Heart Center’S Data Registry, Journal of Tehran University Heart Center (2020)

27. Short-Term Safety and Long-Term Benefits of Stent Postdilation After Primary Percutaneous Coronary Intervention: Results of a Cohort Study, Catheterization and Cardiovascular Interventions (2020)

28. The Association of Statins for Secondary Prevention With Progression to Diabetes in Patients With Prediabetic State After Coronary Artery Bypass Graft Surgery: A Retrospective Cohort Study, Journal of Diabetes and its Complications (2020)

29. The Impact of a Dedicated Coronavirus Disease 2019 Primary Angioplasty Protocol on Time Components Related to St-Segment Elevation Myocardial Infarction Management in a 24/7 Primary Percutaneous Coronary Intervention–Capable Hospital, Kardiologia Polska (2020)

30. Twelve-Year History of Stemi Management in Tehran Heart Center: Concomitant Reduction of In-Hospital Mortality and Hospitalization Length, Archives of Iranian Medicine (2020)

31. Cha2ds2-Vasc Score As an Independent Predictor of Suboptimal Reperfusion and Short-Term Mortality After Primary Pci in Patients With Acute St Segment Elevation Myocardial Infarction, Medicina (Lithuania) (2019)

32. Correlation Between the Serum Procalcitonin Level and the Extension and Severity of Coronary Artery Disease in Patients With Non-St-Segment Elevation Myocardial Infarction, Cardiovascular Endocrinology and Metabolism (2019)

33. Does Invasive Treatment Increase the Long-Term Survival of St-Elevation Myocardial Infarction Patients With a History of Coronary Artery Bypass Graft Surgery?, Journal of Tehran University Heart Center (2019)

34. Effect of Age on Procedural Success, Complications, and Clinical Outcome From a Large Angioplasty Registry, Critical Pathways in Cardiology (2019)

35. Effects of High Dose Atorvastatin Before Elective Percutaneous Coronary Intervention on Highly Sensitive Troponin T and One Year Major Cardiovascular Events; a Randomized Clinical Trial, IJC Heart and Vasculature (2019)

36. Pre-Hospital Delay and Its Contributing Factors in Patients With St-Elevation Myocardial Infarction; a Cross Sectional Study, Archives of Academic Emergency Medicine (2019)

37. Single Long Stents Versus Overlapping Multiple Stents in the Management of Very Long Coronary Lesions: Comparisons of Procedures and Clinical Outcomes, Journal of Tehran University Heart Center (2019)

38. Strategies to Reduce the Door-To-Device Time in St-Elevation Myocardial Infarction Patients, Journal of Tehran University Heart Center (2019)

39. Time to Treatment and In-Hospital Major Adverse Cardiac Events Among Patients With St-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (Pci) According to the 24/7 Primary Pci Service Registry in Iran: Protocol for a Cross-Sectional Study, JMIR Research Protocols (2019)

40. Are Prior Aspirin Users With St-Elevation Myocardial Infarction at Increased Risk of Adverse Events and Worse Angiographic Features?, Critical Pathways in Cardiology (2018)

41. Cardiac Centre of Excellence: The Tehran Heart Center, European Heart Journal (2018)

42. Comparing Serum Level of Vitamin D3 in Patients With Isolated Coronary Artery Ectasia and Normal Coronary Artery Individuals, Archives of Iranian Medicine (2018)

43. Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention, Journal of Tehran University Heart Center (2018)

44. Novel Scoring System for Prediction of Cardiac Syndrome X: In Women With Typical Angina and a Positive Exercise Tolerance Test, Texas Heart Institute Journal (2018)

45. Predictors of Long-Term Major Adverse Cardiac Events Following Percutaneous Coronary Intervention in the Elderly, Archives of Iranian Medicine (2018)

46. Predictors of Major Adverse Cardiac Events Following Elective Stenting of Large Coronary Arteries, Indian Heart Journal (2018)

47. Protection From Reperfusion Injury With Intracoronary N-Acetylcysteine in Patients With Stemi Undergoing Primary Percutaneous Coronary Intervention in a Cardiac Tertiary Center, American Journal of Cardiovascular Drugs (2018)

48. Two-Year Follow-Up of Patients With Unstable Angina/Non-St Segment Elevation Myocardial Infarction Undergoing Early Invasive Strategy: Predictors of Normal or Near-Normal Coronary Angiography and Mortality, Critical Pathways in Cardiology (2018)

49. Association of Serum Gamma-Glutamyltransferase and Premature Coronary Artery Disease, Netherlands Heart Journal (2017)

50. Comparing the Effect of Cardiac Biomarkers on the Outcome of Normotensive Patients With Acute Pulmonary Embolism, Monaldi Archives for Chest Disease (2017)

51. Effect of High-Dose Allopurinol Pretreatment on Cardiac Biomarkers of Patients Undergoing Elective Percutaneous Coronary Intervention: A Randomized Clinical Trial, American Journal of Therapeutics (2017)

52. Impact of Sex on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention, Critical Pathways in Cardiology (2017)

53. Potential Role of Allopurinol in Preventing Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial, Clinical Drug Investigation (2017)

54. Biodegradable-Polymer Biolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study, Texas Heart Institute Journal (2016)

55. Comparing Clinical Outcomes for a Twelve-Month Trial of Zotarolimus- and Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Data From the Thcric Registry, Therapeutic Advances in Cardiovascular Disease (2016)

56. Effect of Coronary Slow Flow on the Longitudinal Left Ventricular Function Assessed by 2-Dimensional Speckle-Tracking Echocardiography, Journal of Ultrasound in Medicine (2016)

57. Evaluating the Effect of Intracoronary N-Acetylcysteine on Platelet Activation Markers After Primary Percutaneous Coronary Intervention in Patients With St-Elevation Myocardial Infarction, American Journal of Therapeutics (2016)

58. One-Year Outcome of Everolimus-Eluting Stents Versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention, Journal of Tehran University Heart Center (2016)

59. A Risk-Scoring Model to Predict One-Year Major Adverse Cardiac Events After Percutaneous Coronary Intervention, Journal of Tehran University Heart Center (2015)

60. Synergistic Effect of Hypertension With Diabetes Mellitus and Gender on Severity of Coronary Atherosclerosis: Findings From Tehran Heart Center Registry, ARYA Atherosclerosis (2015)

61. The Impact of Cytochrome P450 2C19 Polymorphism on the Occurrence of One-Year In-Stent Restenosis in Patients Who Underwent Percutaneous Coronary Intervention: A Case-Match Study, Anadolu Kardiyoloji Dergisi (2015)